Bücher Wenner
Olga Grjasnowa liest aus "JULI, AUGUST, SEPTEMBER
04.02.2025 um 19:30 Uhr
Diagnosis and Management of Hereditary Cancer
Tabular-Based Clinical and Genetic Aspects
von John W Henson, Robert G Resta
Verlag: Elsevier Science
Gebundene Ausgabe
ISBN: 978-0-323-90746-0
Erschienen am 14.04.2021
Sprache: Englisch
Format: 231 mm [H] x 157 mm [B] x 30 mm [T]
Gewicht: 748 Gramm
Umfang: 384 Seiten

Preis: 148,50 €
keine Versandkosten (Inland)


Jetzt bestellen und voraussichtlich ab dem 29. November in der Buchhandlung abholen.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

148,50 €
merken
zum E-Book (EPUB) 130,00 €
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis
Biografische Anmerkung

Many hereditary cancer syndromes are linked to alterations in single genes. Detection and clinical interpretation of these alterations can guide cancer risk reduction for patients and their families through screening, prophylactic measures, and other strategies. Diagnosis and Management of Hereditary Cancer summarizes hereditary syndromes and their associated cancers and genes. The information is presented in 50 practice-enhancing tables that relate clinical, genetic, diagnostic, and management aspects in a manner that has previously not been available in a single reference. Intended to guide the specialist as well the novice, this volume will elevate the care of hereditary cancer patients and their families.



I. Genetics II. Genetic Testing III. Clinical Features IV. Tumors - Syndromes - Genes V. Classic Hereditary Cancer Syndromes



Dr. Henson is director of the Hereditary Cancer Clinic at the Georgia Cancer Center, Medical College of Georgia, Augusta University, in Augusta, Georgia, USA. He has practiced neuro-oncology for over 25 years and is a well-published leader in several related fields, with over 125 papers and book chapters. He attended the Intensive Course in Cancer Genomic Risk Assessment at City of Hope in 2018. He was previously Chief of Oncology Services at Piedmont Healthcare and on the staff of Massachusetts General Hospital and the faculty of Harvard Medical School for 17 years. Dr. Henson is a member of numerous societies, including as an affiliate member of the American College of Medical Genetics.


andere Formate